Drug details

Moderiba (ribavirin tablets)

type of Hepatitis B Hepatitis C Agents, RSV Agents

Moderiba (ribavirin) is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in patients 5 years of age and older with compensated liver disease not previously treated with interferon alpha, and in adult CHC patients coinfected with HIV.

The drug is often used to treat Hepatitis C , HIV , Liver disease .

This drug may have the following side effects:

• fever,
• headache
• fatigue,
• weakness,
• muscle pain, and

The following drugs are related to Moderiba, either as a replacement or used together:

• Copegus (ribavirin)
• Daklinza (daclatasvir tablets)
• Viekira XR (dasabuvir, ombitasvir, paritaprevir, and ritonavir extended-release tablets)
• Zepatier (elbasvir and grazoprevir tablets)
• Epclusa (sofosbuvir and velpatasvir fixed-dose combination tablets)
• Mavyret (glecaprevir and pibrentasvir)
• Harvoni (ledipasvir and sofosbuvir tablets)
• Intron A - Rebetol (ribavirin, interferon alfa-2b, recombinant)
• Olysio (simeprevir hard gelatin capsules)
• Technivie (ombitasvir, paritaprevir and ritonavir tablets)
• Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)
• Pegasys (peginterferon alfa-2a)
• PegIntron and Rebetol Combo Pack (peginterferon alfa-2b and ribavirin combo pack)
• Rebetol (ribavirin)
• Virazole (ribavirin)
• Vosevi (sofosbuvir)
• Sovaldi (sofosbuvir tablets)